Senate investigations panel to probe Mylan's EpiPen pricing

By REUTERS
September 7, 2016 22:34

The US Senate's permanent subcommittee on investigations has decided to look into Mylan Pharmaceuticals' pricing of the EpiPen, according to a press release issued on Wednesday.

The release described the probe as a "preliminary inquiry."


Related Content

Breaking news
September 19, 2019
Rivlin: Even today it's not clear where the Knesset is headed

By JERUSALEM POST STAFF